3641 - 3650 of 8808 Results
Title
Year
-
OPENTitle: Detecting rhythmic spiking through the power spectra of point process model residualsJournal Name: Journal of Neural EngineeringPublisher: IOP PublishingVol: 21Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1088/1741-2552/ad6188Best OA location URL: https://doi.org/10.1088/1741-2552/ad6188Citation Count: 2
-
OPENTitle: Parkinson’s disease variant detection and disclosure: PD GENEration, a North American studyJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 8Start Page: 2668End Page: 2679Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awae142Best OA location URL: https://escholarship.org/uc/item/1tc6321gCitation Count: 38
-
OPENTitle: Loss-of-function variants in ITSN1 confer high risk of Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00752-9Best OA location URL: https://www.nature.com/articles/s41531-024-00752-9.pdfCitation Count: 4
-
OPENTitle: A worldwide study of white matter microstructural alterations in people living with Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-024-00758-3Best OA location URL: https://doi.org/10.1038/s41531-024-00758-3Citation Count: 6
-
OPENTitle: MRI subtypes in Parkinson’s disease across diverse populations and clustering approachesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00759-2Best OA location URL: https://doi.org/10.1038/s41531-024-00759-2Citation Count: 6
-
OPENTitle: Transcriptomics and weighted protein network analyses of the LRRK2 protein interactome reveal distinct molecular signatures for sporadic and LRRK2 Parkinson’s DiseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00761-8Best OA location URL: https://www.nature.com/articles/s41531-024-00761-8.pdfCitation Count: 3
-
OPENTitle: Contrastive machine learning reveals Parkinson’s disease specific features associated with disease severity and progressionJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s42003-024-06648-xBest OA location URL: https://doi.org/10.1038/s42003-024-06648-xCitation Count: 3
-
OPENTitle: Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson diseaseJournal Name: Nature Mental HealthPublisher: Springer Science and Business Media LLCVol: 2Issue #: 8Start Page: 916End Page: 923Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s44220-024-00256-8Best OA location URL: https://www.nature.com/articles/s44220-024-00256-8.pdfCitation Count: 6
- Lack of genetic evidence for NLRP3 inflammasome involvement in Parkinson’s disease pathogenesis2024OPENTitle: Lack of genetic evidence for NLRP3 inflammasome involvement in Parkinson’s disease pathogenesisJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-024-00744-9Best OA location URL: https://doi.org/10.1038/s41531-024-00744-9Citation Count: 1
-
RESTRICTEDTitle: Considerations for clinical trial design and conduct in the evaluation of novel advanced therapeutics in neurodegenerative diseaseJournal Name: International Review of NeurobiologyPublisher: ElsevierVol:Issue #:Start Page: 235End Page: 279Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/bs.irn.2022.09.006Citation Count: 0